However, CD8+/CD45+ cells in the ischemic brain were decreased in the IL‐2mAb treated stroke brain, while the MFI of CD44 on CD8+ T cells was significantly reduced (P < 0.01, Figure 4C). The gene discussed is PTPRC; the disease is stroke disorder.